Aspirin and Preeclampsia

Summary

Aspirin and Preeclampsia is a clinical trial^[1].

Key Facts

• Aspirin and Preeclampsia is in the country of United States^[2].
• Aspirin and Preeclampsia's instance of is recorded as clinical trial^[3].
• Aspirin and Preeclampsia's start time is recorded as +2021-02-15T00:00:00Z^[4].
• Aspirin and Preeclampsia's end time is recorded as +2026-01-01T00:00:00Z^[5].
• Aspirin and Preeclampsia's main subject is recorded as pre-eclampsia^[6].
• Aspirin and Preeclampsia's number of participants is recorded as {'unit': '1', 'amount': '+180'}^[7].
• Aspirin and Preeclampsia's title is recorded as Aspirin to Prevent Cardiac Dysfunction in Preeclampsia^[8].
• Aspirin and Preeclampsia's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[9].
• Aspirin and Preeclampsia's ClinicalTrials.gov ID is recorded as NCT04479072^[10].
• Aspirin and Preeclampsia's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+45'}^[11].
• Aspirin and Preeclampsia's research intervention is recorded as Aspirin^[12].
• Aspirin and Preeclampsia's research intervention is recorded as non-steroidal anti-inflammatory drug^[13].
• Aspirin and Preeclampsia's research intervention is recorded as non-opioid analgesic^[14].
• Aspirin and Preeclampsia's research intervention is recorded as analgesic^[15].
• Aspirin and Preeclampsia's research intervention is recorded as peripheral nervous system agent^[16].
• Aspirin and Preeclampsia's research intervention is recorded as disease-modifying antirheumatic drug^[17].
• Aspirin and Preeclampsia's research intervention is recorded as fibrinolytic agents^[18].
• Aspirin and Preeclampsia's research intervention is recorded as fibrin modulating agent^[19].
• Aspirin and Preeclampsia's research intervention is recorded as mechanism of action^[20].
• Aspirin and Preeclampsia's research intervention is recorded as platelet aggregation inhibitors^[21].
• Aspirin and Preeclampsia's research intervention is recorded as cyclooxygenase inhibitors^[22].
• Aspirin and Preeclampsia's research intervention is recorded as enzyme inhibitor^[23].
• Aspirin and Preeclampsia's clinical trial phase is recorded as phase IV clinical trial^[24].
• Aspirin and Preeclampsia's research site is recorded as University of Chicago^[25].
• Aspirin and Preeclampsia's research subject recruitment status is recorded as recruiting^[26].